MINNEAPOLIS, Aug. 19, 2013/PRNewswire/ -- TECHNE Corporation (Nasdaq:TECH) announced today that the Company's s executive management will host a conference call beginning at 3:30 p.m. Central Time on September 19, 2013, to discuss its global strategic vision and to answer questions.
To obtain participation information for the conference call, please register at http://event.netbriefings.com/event/techne/Live/strategy. A live and archived audio webcast will be available through the Investors section of the Company's website at www.techne-corp.com effective September 19, 2013. An archived webcast will remain available on the Company's website for fourteen (14) days following the call.
About TECHNE Corporation
TECHNE Corporation and Subsidiaries (the Company) are engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through the Company's two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.
R&D Systems is a specialty manufacturer of biological products. R&D Systems has four subsidiaries: BiosPacific, Inc. (BiosPacific), located in Emeryville, California, Boston Biochem, Inc., located in Cambridge, Massachusetts, Bionostics Holdings Limited (Bionostics), operating in Devens, Massachusetts, and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. Boston Biochem is a leading developer and manufacturer of ubiquitin-related research products. Bionostics is a leading supplier of control solutions used in point of care blood glucose and blood gas testing.
R&D China and R&D Europe distribute the Company's biotechnology products. R&D Europe has two subsidiaries: Tocris Holdings Ltd. (Tocris) of Bristol, England and R&D Systems GmbH, a German sales operation. Tocris is a leading supplier of chemical reagents for non-clinical life science research.
SOURCE TECHNE Corporation